Interactive cardiovascular and thoracic surgery
-
Interact Cardiovasc Thorac Surg · Apr 2013
Are we running out of thoracic or cardiac surgeons? Demography of thoracic and cardiac surgeons in France in 2012.
The aim of the study was to accurately evaluate the inflow and outflow of thoracic and cardiac surgeons in France. ⋯ France will not run out of cardiothoracic surgeons. The inflow compensates for the outflow of surgeons liable to stop their activity in the next 10 years.
-
Interact Cardiovasc Thorac Surg · Apr 2013
ReviewShould mediastinal lymphadenectomy be performed during lung metastasectomy of renal cell carcinoma?
A best evidence topic was constructed according to a structured protocol. The question addressed was whether radical mediastinal lymphadenectomy should be performed during lung metastasectomy of renal cell carcinoma (RCC). Of the 13 papers found through a report search, seven represent the best evidence to answer this clinical question. ⋯ Indeed, most patients referred to surgery are younger, fitter, and have fewer metastases. Consequently, the survival gain could be biased, related more to the resectability and the good performance status rather to the resection itself. Consequently, although these preliminary results are interesting, they must be interpreted with caution.
-
Interact Cardiovasc Thorac Surg · Apr 2013
Multicenter StudyPreoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery.
Preoperative atrial fibrillation (PAF) has been associated with poorer early and mid-term outcomes after isolated valvular or coronary artery bypass graft surgery. Few studies, however, have evaluated the impact of PAF on early and mid-term outcomes after concomitant aortic valve replacement and coronary aortic bypass graft (AVR-CABG) surgery. ⋯ PAF is associated with reduced mid-term survival after concomitant AVR-CABG surgery. Patients with PAF undergoing AVR-CABG should be considered for a concomitant surgical ablation procedure.
-
Interact Cardiovasc Thorac Surg · Apr 2013
Risk factors affecting the survival rate in patients with symptomatic pericardial effusion undergoing surgical intervention.
The optimal management and treatment of pericardial effusion are still controversial. There is limited data related to the risk factors affecting survival in these patients. The aim of this study was to determine the risk factors affecting the survival rate of patients with symptomatic pericardial effusion who underwent surgical interventions. ⋯ In the surgical management of pericardial effusion, patients with underlying malignant disease, especially with lung cancer, patients with a detectable invasion of thorax in computed tomography and those with positive echocardiographic findings compatible with tamponade have a poor survival. Therefore, minimally invasive therapies could be considered as a more acceptable alternative for these high-risk patients.
-
Interact Cardiovasc Thorac Surg · Apr 2013
Case ReportsSuccessful treatment of endoleak Type I with uncovered EX-L stent after thoracic endovascular aneurysm repair.
Treatment of endoleaks after thoracic endovascular repair remains challenging, particularly when the proximal landing zone is small and partly includes the origin of the neck vessels. We report a Type Ia endoleak, occurring after thoracic endovascular aneurysm repair, which was successfully treated with a novel uncovered nitinol stent. With this success, we were able to avoid a conventional surgery to treat the endoleak.